Weise Prescription Shop, Inc.
Outcome
Owner Gilbert Weise Jr. pleaded guilty January 2022 to conspiracy to dispense controlled substances without legitimate medical purpose; DEA issued Order to Show Cause July 7, 2022, and revoked pharmacy registration in August 2023; Weise faces up to 5 years prison.
Details
Weise Prescription Shop, Inc. — Pill Mill Partnership with Georgia Pain Clinic (2014–2023)
Outcome: Pharmacy owner Gilbert Nelson Weise Jr., 58, of Jacksonville, Florida, pleaded guilty in January 2022 to conspiracy to dispense controlled substances without a legitimate medical purpose; DEA issued an Order to Show Cause on July 7, 2022, and revoked the pharmacy's DEA registration in a Decision and Order dated August 14, 2023.
Gilbert Nelson Weise Jr. owned and operated Weise Prescription Shop in Jacksonville, Florida. Between October 9, 2014, and June 13, 2017, Weise and co-conspirators participated in a scheme involving Coastline Physical Medicine and Rehabilitation, Inc. in St. Marys, Georgia — a pain clinic where drug-seeking customers typically paid approximately $300 cash to receive prescriptions for hydromorphone, oxycodone, hydrocodone, and other controlled substances.
Weise's pharmacy fulfilled prescriptions generated by this cash-pay pain clinic, dispensing controlled substances to drug-seeking customers without legitimate medical purpose. The conspiracy operated across state lines, with the prescribing occurring in Georgia and the dispensing at the Jacksonville, Florida pharmacy.
Weise pleaded guilty to a charge of conspiracy to dispense controlled substances without a legitimate medical purpose and not in the usual course of professional practice. On July 7, 2022, the DEA issued an Order to Show Cause to Weise Prescription Shop Inc. proposing revocation of the pharmacy's registration because Weise had been convicted of a felony offense relating to federal controlled substance laws under 21 U.S.C. 824(a)(2). The DEA's final Decision and Order was published in the Federal Register on August 14, 2023.
Primary Source: Weise Prescription Shop Inc.; Decision and Order (Fed. Reg. Aug. 14, 2023)
How Crucible Prevents This
Weise operated in coordination with a pain clinic in Georgia that charged $300 cash per visit for prescriptions — a documented cash-pay mill. Crucible's prescriber-concentration monitoring would have flagged the pharmacy's dependence on a single out-of-state pain clinic as a diversion risk requiring escalation, as would the 100% cash-payment pattern for those prescriptions.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works